These results were consistent with previous studies in humans in which specific IgA antibodies were detected in nasal mucosa following infection or nasal vaccination, thereby providing protection against Streptococcus pneumoniae infection or colonization (15, 38). The gene discussed is CD79A; the disease is infection.